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An innovative pH-switchable colloidal system that can be exploited for site-selective anticancer 
drug delivery has been generated by liposomes decoration with a new novel synthetic non-
peptidic oligo-Arginine cell-penetration enhancer (CPE) and a quenching  PEGylated counterpart 
that detaches from the vesicle surface under the acidic conditions of tumors. The CPE module 
(Arg4-DAG) is formed by four arginine units conjugated to a first generation (G1) 2,2-
bis(hydroxymethyl)propionic acid (bis-MPA)/2,2-bis(aminomethyl)propionic acid (bis-AMPA) 
polyester dendron terminating with 1,2-distearoyl-3-azidopropane for liposome bilayer insertion. 
The zeta potential of the Arg4-DAG -decorated liposomes increased up to +32 mV as the Arg4-
DAG /lipids molar ratio increased. The Arg4-DAG liposome shielding at pH 7.4 was provided by 
methoxy-PEG5kDa-polymethacryloyl sulfadimethoxine (mPEG5kDa-SDM8) with 7.1 apparent pKa. 
Zeta potential, surface plasmon resonance and synchrotron small-angle X-ray scattering analyses 
showed that at pH 7.4 mPEG5kDa-SDM8 associates with polycationic Arg4-DAG-decorated 
liposomes yielding liposomes with neutral zeta potential. At pH 6.5, which mimics the tumor 
environment, mPEG5kDa-SDM8 detaches from the liposome surface yielding Arg4-DAG exposure. 
Flow cytometry and confocal microscopy showed a 30-fold higher HeLa cancer cell association 
of the Arg4-DAG-decorated liposomes compared to non-decorated liposomes. At pH 7.4, the 
mPEG5kDa-SDM8 coated liposomes undergo low cell association while remarkable cell 
association occurred at pH 6.5, which allowed for the controlled intracellular delivery of model 





New generation high-performance drug delivery colloidal systems have been developed to 
increase the tumor targeting and reduce off-target toxicity of chemotherapeutic agents.1-2 These 
systems are often designed to exploit the peculiar physio-pathological features at the tumor site 
to timely and spatially control the drug release.3-4  
Targeting agents have been widely used to decorate drug nanocarriers for selective 
biorecognition of cells and intracellular delivery of therapeutic agents. However, biorecognition 
approaches may fail because tumor cell populations are extremely heterogeneous and expression 
levels of membrane targets can significantly vary.5-6 Furthermore, multivalent targeted 
nanocarriers may affect cellular receptor recycling efficiency during endocytosis, which limits 
further cargo internalization.7  
 A different approach for intracellular delivery of colloidal vehicles of anticancer drugs exploits 
cell penetration peptides (CPPs). Cell penetrating peptides, namely natural and  synthetic TAT 
(transactivator of transcription)-derived peptides,8 have been exploited for intracellular delivery 
of a variety of colloidal cargoes, including proteins, oligonucleotides, nanovesicles and 
nanoparticles.9-10 Although a general consensus on the uptake mechanism of CPPs has not yet 
been achieved, two major cellular mechanisms of endocytic and non-endocytic pathways have 
been proposed. These mechanisms have been reported to depend on the transducing peptide 
sequences, the biophysical characteristics of the cargo and the cell type-dependent composition 
of the plasma membrane.11-12 However, high positive charge density resulting from protonation  
of the basic amino acid residues including arginine (Arg), lysine (Lys) and histidine (His) has 
been shown to be a structural requisite for CPP activity. Indeed, high positively charged  amino 
 4 
acid  sequences are engaged providing charge-to-charge interactions with anionic proteoglycans, 
in particular heparin sulfate proteoglycans (HSPGs), on the cell membrane corona.12 Brock et al 
reported that the cell up-take efficiency of CPPs increases with the decrease of the CPPs/HSPGs 
molar ratio and with the increase of the local Arg density in the peptide sequence.13-14  
The guanidinium groups of Arg in the CPP sequences are structurally planar “Y” shaped 
molecules with delocalized positive charges, which allows for both electrostatic and hydrogen 
bonding with anionic and polar molecules.15 Accordingly, Arg interact through bi- or multi-
dentate hydrogen bonds with anionic charges on the cell membrane surfaces, thus triggering 
saddle-splay curvature, which is correlated with the permeation ability of CPPs. On the other 
hand, protonated Lys is unable to promote the curvature in lipidic membranes and consequent 
cell penetration.12, 16 Based on these evidences, guanidinium-rich synthetic analogues of the 
CPPs have been developed.12, 15 It has been reported that the structural conformation of CPPs is 
not a prerequisite for their cell penetration activity even though the conformation dictates their 
penetration mechanism. CPPs that possess random conformation, such as TAT or Arg9, undergo 
endocytic pathway rather than translocation, which is typical for CPPs with alfa-helix and beta-
strand conformations. Thus, the absence of a specific structural conformation of this class of cell 
penetration systems may be preferred when they are exploited for the delivery of 
macromolecular and colloidal cargoes and thus appealing for biomedical applications.17 
Despite CPPs have extraordinary potential in the development of high performance drug delivery 
systems, they suffer from cell non-selectivity, thus yielding unspecific tissue association and 
random biodistribution, which represents a major drawback for their biomedical application for 
therapeutic purposes. Therefore, the use of CPPs for cell targeting requires dedicated molecular 
strategies to provide drug nanocarriers  with site-selectivity. Furthermore, the use of these 
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polypeptides is limited by their poor stability in biological environment due to proteolytic 
degradation.18-19 To overcome these limitations, we developed a stable novel non-peptide Arg 
based dendritic cell penetrating enhancer (CPE), tetraArg-[G-1]-distearoyl glycerol (Arg4-DAG) 
for liposomes decoration. Arg4-DAG contains a non-symmetrical dendritic scaffold based on 
2,2-bis(hydroxyl-methyl)propionic acid (bis-MPA) building block that, on one side, terminates 
with oligo-cationic Arg with higher charge density than that found in natural linear CPPs, and, 
on the opposite side, with a hydrophobic tail to anchor the CPE to the liposome bilayer. In order 
to enable the Arg4-DAG decorated liposomes with tumor targeting behavior, the cationic charges 
were charge-to-charge quenched with a releasable PEGylating agent, mPEG5kDa-
oligomethacriloyl sulfadimethoxine (mPEG5kDa-SDM8), which includes a pH-sensitive poly-
anionic block. The mPEG5kDa-SDM8 coated Arg4-DAG decorated liposomes have been designed 
to bestow pH-switchable liposomes.  Under physiological conditions at pH 7.4, namely in blood, 
the liposomes possess stealth features that minimize the association of the carrier to healthy 
cells. Under the acid environment of the tumor,4, 20 the oligo-Arg moieties on the liposome 
surface are revealed upon mPEG5kDa-SDM8 detachment thus enhancing the association of the 
liposomes to cancer cells.  
 
2. EXPERIMENTAL SECTION 
 
2.1 Materials and equipment 
Chemicals and equipment are reported in the electronic supplementary information (ESI). 
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2.2 Design and synthesis of the Cell Penetration Enhancer (CPE) module tetraArg-[G1]-
distearoyl glycerol (Arg4-DAG)  
First (G1) and  second (G2) generation bis-MPA dendrons bearing 4 and 8 Arg, respectively, and 
functionalized with diacyl glycerol, were designed in silico by ChemDraw (PerkinElmer Inc. 
Waltham, MA, USA). The structures underwent energy minimization using Force MMFF94x by 
Molecular Operating Environment (MOE) software (Chemical Computing Group Inc. Montreal, 
Canada). The data were elaborated assuming Arg monomers as dots centred on guanidinium 
carbon. 
The synthetic procedure to obtain the first-generation (G1) CPE dendron, Arg4-DAG (14), is 
shown in Scheme 1. Full details of the synthetic strategies used and characterization of the final 
product and intermediates are provided in the ESI.  
 
Scheme 1. Synthesis of the first-generation tetra-arginyl dendritic 3-(1,2,3-triazol)propane-1,2-
distearate cell penetration enhancer for the decoration of liposomes.a 
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aReagents and conditions: (i) BnBr, KOH, DMF, 100 °C, 15 h; (ii) TsCl, Py, DMAP, CH2Cl2, 60 °C, 4 h; (iii) NaN3, 
DMF, 90 °C, 16 h; (iv) 1) PtO2, H2, (Boc)2O, MeOH, rt, 4 h; 2) 10% Pd/C, H2, MeOH, rt, 3 h (v) DMP, PTSA, 
Acetone, rt, 2 h; (vi) DCC, CH2Cl2, rt, 4 h; (vii) 2-propyn-1-ol, Py, DMAP, CH2Cl2, rt, 15 h; (viii) Dowex 50W-X8 
(H+-form), MeOH, rt, 6 h; (ix) 1) 4, DCC, CH2Cl2, rt, 16 h; 2) 8, Py, DMAP, CH2Cl2, rt, 16 h; (x) 1) CH2Cl2/TFA 
(1:1), rt, 2.5 h; 2) Boc-Arg(Pbf)-OH, HOBt, EDC, DIPEA, DMF, rt, 16 h; (xi) stearoyl chloride, Py, CH2Cl2, rt, 16 
h; (xii) NaN3, DMF, 100 °C, 15 h; (xiii) CuI (10 mol %), AcOH (20 mol %), DIPEA (20 mol %), sodium ascorbate 
(10 mol %), CH2Cl2, rt, 24 h; (xiv) 1) CH2Cl2/TFA (2.5:1), rt, 24 h; 2) CH3CN/H2O + 0.05% TFA (1:1), Amberlite 
IRA-900 (Cl--form). 
 
Briefly, compound (14) was synthesized by the Cu(I)-catalyzed Huisgen 1,3-dipolar 
cycloaddition (“click” reaction) between the azide terminated distearoyl propane anchoring unit 
(12) and the alkynic dendron (10) to give the Pbf-Boc-protected precursor (13), followed by TFA 
mediated deprotection of the Arg units (xiii and xiv, Scheme 1). The 3-azidopropane-1,2-
distearate (12) was prepared by a two-step high yield procedure from commercially available 
(±)-3-chloro-1,2-propanediol (3-MCPD): acylation with stearoyl chloride followed by 
nucleophilic substitution of chloride with azide (xi and xii, Scheme 1). The synthesis of the four 
branched alkynic tetra-Boc-arginyl(Pbf) scaffold (10) was achieved via anhydride coupling 
between 2,2-(bis((tert-butoxycarbonyl)amino)methyl)-propanoic acid (4) and propargyl 2,2-
bis(hydroxymethyl)propanoate (8) to yield (9) (ix, Scheme 1), followed by TFA mediated Boc 
deprotection and coupling with Boc-Arg(Pbf)-OH (x, Scheme 1). Compound (8) was synthesized 
according the procedure reported by Barnard et al. with only slight modifications21 (v - viii, 
Scheme 1). Compound (4) was synthesized by benzylation of the carboxylic function of bis-
MPA followed by tosylation of the two free hydroxyl groups and nucleophilic substitution of the 
tosylate with azide to obtain (3) which was then reduced in a one-pot hydrogenation procedure 
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involving two sequential steps: the first in the presence of PtO2 and Boc-anhydride to obtain the 
corresponding Boc-protected diamine and the second in the presence of Pd/C to cleave the 
benzyl protecting group and obtain the desired intermediate (4) (i - iv, Scheme 1). 
  
2.3 Synthesis and characterization of the pH-sensitive copolymer mPEG-(poly-
methacryloyl sulfadimethoxine) (mPEG5kDa-SDM8) 
mPEG-polySDM (17) was synthetized in a two-step procedure, according to a modified strategy 
reported in the literature.22 The activated mPEG5 kDa-NH-CO-C-(CH3)2)-Br (16) was obtained by 
α-bromoisobutyryl bromide reaction with mPEG5kDa-NH2 (yield 90%). The TNBS 
spectrophotometric analysis confirmed the complete functionalisation of the amino groups of 
mPEG5kDa–NH2 with α-bromoisobutyryl bromide. The integrals of the 
1H NMR signals (δ 3.65 
for the oxyethylene monomers of PEG and δ 1.9 for the two methyl groups of the α-
bromoisobutyryl amide) were in agreement with a 1:1 PEG/α-bromoisobutyryl amide molar ratio 
of the AGET-ATRP initiator. The synthesis of mPEG-polySDM (17) was performed by AGET-
ATRP polymerization of  methacryloyl sulfadimethoxine (SDM, (15)) using a 1:12 mPEG5 kDa-
NH-CO-C-(CH3)2)-Br/SDM molar ratio. The polymer was isolated with a 67% yield. The 
1H 
NMR integrals (Figure S1 in ESI) of the signals at 6.0 ppm and 3.5 ppm, corresponding to the 
pyrimidyl hydrogen of SDM and the PEG oxyethylene monomers, respectively, showed that the 
co-polymer included, on average, 8 methacryloyl sulfadimethoxine monomers which was 
confirmed by UV–Vis spectroscopic analysis and iodine assay. 
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2.4 Liposome preparation 
Liposomes were prepared according to the “thin layer rehydration technique” method,23  using 
a 2:1 mol/mol hydrogenated soy phosphatidylcholine/cholesterol mixture. Briefly, 10 mg of the 
lipid mixture was dissolved in 1.5 mL of CH2Cl2 and the organic solvent was removed under 
reduced pressure by rotavapor to form a lipid film and then overnight to remove any CH2Cl2 
trace. The lipid film was rehydrated with 200 µL of buffer (0.01 M phosphate, 0.15 M NaCl at 
pH 7.4 or 0.01 M HEPES, 0.15 M NaCl at pH 7.4 and processed with ten freeze-thawing cycles.  
CPE-decorated liposomes were prepared by adding 0.5 mL liposome dispersions (10 mg/mL 
lipid concentration) of increasing volumes of a 5 mg/mL Arg4-DAG solution in the same buffer 
of the liposome dispersion in order to yield Arg4-DAG in the range of 1-8 mol% with respect to 
lipids. The liposomes were sonicated for 60 sec with a Ultrasonic Homogenizer (Omni 
International, Kennesaw, GA-USA) set at 20% power. Non-associated CPE was removed by 
liposome centrifugation for 30 min at 11,000 rpm. The liposomes were redispersed with the same 
buffer to a lipid concentration of 5 mg/mL and extruded eleven times at 60 °C through a 200-nm 
cut-off polycarbonate membrane. The formulations were then incubated at 37 °C for 1 hour and 
the Arg4-DAG content was assessed by Sakaguchi assay as reported in the ESI. 
Liposomes decorated with 4 mol% of Arg4-DAG with respect to lipids were incubated with 
increasing amounts of mPEG5kDa-SDM8 (0-4 mol% mPEG5kDa-SDM8/lipids molar ratio) in the 
same buffer to obtain PEG coated pH-sensitive formulations and diluted 50 times either with 
0.01 M HEPES, 0.15 M NaCl at pH 7.4 and 7.0, or with 0.01 mM MES, 0.15 M NaCl at pH 6.5 
and 6.0 and the zeta potential was assessed as a proxy for the Arg4-DAG shielding and 
unshielding, respectively. 
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Liposomes decorated with 4 mol% of mPEG5kDa-DSPE with respect to lipids were prepared as 
control with non-pH releasable PEG using a 5 mg/mL stock solution of mPEG5kDa-DSPE in the 
same buffers.  
Stability of liposomes over time was assessed at predefined time points by size and zeta 
potential analysis. 
Fluorescent liposomes were prepared by including 0.2 mol% Rhodamine-DHPE with respect to 
lipids in the lipid film. 
  
2.5 Particle size and zeta potential measurements 
Size and polydispersity, and zeta potential of liposomes were assessed by Dynamic Light 
Scattering (DLS)  using a NanoZS Zetasizer (Malvern, Workcestershire, UK). The analyses were 
performed by using liposome dispersions obtained by dilution as reported above in different 
buffers: 0.01 M phosphate, 0.15 M NaCl (PBS) at pH 7.4 and 6.5; 0.01 M phosphate containing 
300 mM mannitol (PBS/mannitol) at pH 7.4 and 6.5; 0.01 M HEPES, 0.15 M NaCl (HEPES) at 
pH 7.4; 0.01 M HEPES containing 300 mM mannitol (HEPES/mannitol) at pH 7.4; 0.01 M 
MES, 0.15 M NaCl (MES) at pH 6.5; 0.01 M MES containing 300 mM mannitol 
(MES/mannitol) at pH 6.5. The liposome size was expressed as z-average. 
Zeta potential analyses were performed using liposomes decorated with 4 mol% of Arg4-DAG 




2.6 SAXS Analysis 
The internal structure of liposomes was analyzed by synchrotron small-angle X-ray scattering 
(SAXS) using an ID02 high-brilliance beamline (ESRF, Grenoble, France), with a beam cross 
section 200×400 µm and wavelength λ = 0.1 nm, investigated momentum transfer region, q = 
(4π/λ) sin(θ), 0.0116 < q < 40 nm-1, 2θ scattering angle.24-25 The corresponding real-space 
length-scale was from 100 to 0.1 nm. Liposome (10 mg/mL lipid concentration), CPE (5 mg/mL) 
and mPEG5kDa-SDM8 (5 mg/mL) solutions in HEPES at pH 7.4 and MES at 6.5 were transferred 
in plastic capillaries (KI-BEAM; ENKI srl, Concesio, Italy), 2 mm internal diameter. 
Measurements were performed at 25 °C and the data were treated for angular regrouping and 
background subtraction, and then reported as scattered radiation intensity as a function of the 
momentum transfer q. 
 
2.7 MP-SPR measurements 
Surface plasmon resonance measurements were performed with a multi-parametric MP-SPR 
Navi™ 200 (BioNavis Ltd., Tampere, Finland) instrument. The system was equipped with two 
temperature controlled independent flow channels, inlet and outlet (waste) tubings, and a manual 
sample injector for both flow channels. The SPR measurements were performed with a laser 
wavelength of 670 nm. The sensor chip temperature was set to 20 °C. CPE-decorated liposomes 
were captured and immobilized on SPR sensors consisting of a thin 6-kD carboxymethyl dextran 
hydrogel layer functionalized with dodecyl lipid anchors.26 The pH-sensitive polymer 
(mPEG5kDa-SDM8) was dissolved in running buffers (HEPES, pH 7.4, and MES, pH 6.5)  to 
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assess polymer/liposome association under different pH conditions. The flow rates used for 
immobilizing the CPE-decorated liposomes and for monitoring the interactions between the pH-
sensitive polymer (mPEG5kDa-SDM8) and immobilized liposomes were 50 and 100 μL/min, 
respectively.  
The SPR sensors were used repeatedly after rejuvenation with an injection series of Hellmanex II 
2% or CHAPS 20 mM, ethanol 80% and Milli-Q water. In between measurements, the sensors 
were stored immersed in CHAPS at 4 °C. During the SPR measurements, the functionalized gold 
sensor slides were first subjected to the running buffer for the respective liposomes for 
approximately 5-10 min until a stable baseline was achieved. In the second phase, the liposomes 
were injected into both flow channels for 25 min, and lastly, the sensor surfaces with the 
immobilized liposomes were exposed to seven sequential injections of  0.4 M, 0.8 M, 1.61 
M, 3.23 M, 6.45 M and 12.9 M pH-sensitive polymer (mPEG5kDa-SDM8) solutions in the 
buffers at pH 7.4 or 6.5.  
 
2.8 Liposome loading and release study  
Liposome loading with BSA-Rhodamine (BSA-Rho) and calcein and the corresponding method 





2.9 Cell cultures 
HeLa cells (human cervical cancer) were grown at 37 °C in DMEM medium supplemented with 
10% (v/v) heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, 100 IU/mL penicillin, 
100 μg/mL streptomycin and 0.25 μg/mL of amphotericin B, with a 5% CO2 atmosphere. The 
cells were harvested by treatment with 0.05% (w/v) trypsin-0.02% (w/v) EDTA solution (Sigma-
Aldrich, St. Louis, MO-USA), suspended in culture medium and seeded at the appropriate cell 
concentration.  
Viability studies were performed by incubation of HeLa cells with the different liposome 
formulations according to the procedure reported in the ESI. 
 
2.10 Cytofluorimetric analysis 
HeLa cells were used to evaluate the internalization of: naked liposomes (plain liposomes); 
PEGylated liposomes (liposomes coated with non-pH-responsive mPEG5kDa-DSPE ); liposomes 
decorated with 2 or 4 mol% of Arg4-DAG; pH-responsive liposomes decorated with 4 mol% 
Arg4-DAG and coated with 4 mol% of mPEG5kDa-SDM8, labelled with rhodamine-DHPE, or 
loaded with BSA-Rho or calcein. The cells were seeded in a 6 well plate at a density of 1×106 
cells/well. After 24 hours, the cells were washed twice with HEPES or MES at pH 7.4 and 6.5 
respectively and incubated for 1 hour at 37 °C with 1 mL of 0.1 mg/mL liposomal dispersion in 
DMEM supplemented with 10% of FBS buffered with 0.1 M HEPES, pH 7.4, or 0.1 M MES, pH 
6.5.27 The medium was removed and the cells were washed three times with fresh PBS at pH 7.4 
and treated for 2 min with 300 µL of 500 g/mL trypsin in PBS without calcium and 
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magnesium. DMEM (1 mL) supplemented with 10% FBS was added to the wells to quench 
trypsin and the cells were recovered and centrifuged at 1,000 rpm for 5 minutes. The cellular 
pellet was resuspended in PBS, pH 7.4, washed twice with the same buffer and recovered by 
centrifugation at 1,000 rpm for 5 minutes. The cell samples were resuspended in 300 μL of PBS 
pH 7.4,  and analysed by flow cytometry using a BD FACScanto II flow cytometer (Biosciences, 
San Jose, Canada) equipped with a FACSDIVA software package. The cell populations were 
gated using forward versus side scatter to exclude debris and dead cells. 
The same protocol was also used with PNT2 cells used as non-cancer cell model.  
 
2.11 Confocal microscopy 
The liposome association to cancer cells and cell uptake were studied by confocal microscopic 
imaging. 
HeLa cells were seeded onto 4-chamber tissue culture microscope slides at a 1×105 
cells/chamber density. After 24 hours (90% confluence), the cells were washed twice with 
HEPES at pH 7.4 or MES at pH 6.5, and the medium replaced with 0.5 mL of 0.1 mg/mL 
liposome dispersions in DMEM supplemented with 10% of FBS buffered with 0.1 M HEPES, 
pH 7.4, or 0.1 M MES, pH 6.5:27 Rhodamine-DHPE labelled naked liposomes (plain  
liposomes), liposomes coated with non-pH-responsive mPEG5kDa-DSPE (PEG/liposomes), 
liposomes decorated with 4 mol% Arg4-DAG (CPE/liposomes), liposomes decorated with 4 
mol% Arg4-DAG and coated with 4 mol% mPEG5kDa-SDM8 liposomes (CPE/pH-sensitive 
polymer / liposomes). Liposomes loaded with BSA-Rho or calcein were also tested. After 
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incubation for 1 hour at 37 °C, the medium was removed and the cells were gently washed three 
times with PBS, pH 7.4, and finally fixed by treatment with 4% paraformaldehyde in PBS, pH 
7.4, for 10 min in an ice bath. The cell membranes were stained by cell incubation with 5 μg/mL 
Alexa Fluor® 633 conjugated wheat-germ agglutinin (WGA-AlexaFluor 633) in PBS, pH 7.4, 
for 10 minutes at room temperature. The cells were then washed with PBS, pH 7.4, and the 
samples were covered with a glass slide using Vectashield® as mounting medium containing 1.5 
μg/mL DAPI for nucleus staining. The samples were maintained at 4 °C in the dark until 
microscopic examination.  
The samples were imaged by confocal laser microscopy using a LSM 800 microscope (Carl 
Zeiss, Jena, Germany) equipped with a 63x, n.a. 1.4, oil immersion objective and a ZEN 2.1 - 
blue edition - software (Carl Zeiss, Jena, Germany). Lasers with emission wavelength at 405, 
488, 561 and 640 nm were used to detect DAPI, calcein, Rhodamine-DHPE and WGA-Alexa 
Fluor 633, respectively. To avoid emission crosstalk, each emission fluorescence was recorded 
independently with specific detector and optical cut-off filter over the entire emission spectrum 
of related chromophores. Image analyses were performed using ImageJ 1.47v (National 
Institutes of Health software package). 
 
2.12 Statistical analysis 
Statistical analyses were performed with XLSTAT software (New York, USA). Two-way 
analysis of variance was used to calculate the threshold of significance. Statistical significance 
was set at p < 0.05. 
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3. RESULTS AND DISCUSSION 
The work presented here was aimed at developing a new novel strategy that provides for 
controlled cell up-take of nanocarriers by exploiting environmentally triggerable cell penetration 
enhancers (CPEs) and reversible stealthing polymers. The nanocarrier has been designed as an 
alternative to systems that exploit conventional “active targeting” based on cell biorecognition. 
Indeed, this nanocarrier can provide for intracellular drug delivery after local 
microenvironmental activation. 
Although many efforts have been done to exploit CPEs, namely TAT derived peptides, to 
ameliorate the therapeutic performance of drug nanocarriers, non-specificity  and lack of 
selective targeting strongly limits their use for fabrication of smart nanomedicines.28-30 
Therefore, CPE exposure control by environmental stimuli is required to generate drug 
nanovehicles for site-selective cell targeting. 
Nanocarrier stealthiness is a requisite to prevent their clearance by RES. On the other hand, 
stealthiness may reduce the interaction of colloidal drug carriers with the target cancer cells, 
which may result in poor access to the cytosol, low intracellular drug delivery and, eventually, 
reduced therapeutic performance.  
Thus, we synthesised a new non-peptide, non-linear CPE and a pH-sensitive stealthing block-
copolymer, which were synergistically combined to produce “smart” liposomes that undergo a 
four-stage targeting process: 1.  circulate in the bloodstream in a dormant conformation; 2. 
passively dispose in the tumor according to the enhanced permeability and retention (EPR) 
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mechanism;31-32 3. are activated by microenvironmentally controlledCPE exposure; 4. are taken-
up by the cells.  
 
3.1 Dendron cell penetration enhancer (CPE) design, synthesis and characterization. 
The novel CPE formed by multiple Arg units to the tips of a first-generation dendritic structure 
was designed in order to develop a molecule with enhanced physicochemical and biological 
features compared to synthetic and natural TAT-like peptides (CPPs), namely high stability 
towards proteases, lack of bioactivity and high biocompatibility. Furthermore, Sheldon reported 
that cell penetrating peptides with dendritic architecture typically outperform their linear 
monomeric homologues in term of cellular uptake.33-34 
Multiple Arg units were conjugated to a first-generation dendritic structure based on a 
bis(aminomethyl)propionic acid (bis-AMPA) branched scaffold anchored to a core of 2,2- 
bis(hydroxymethyl)propionic acid (bis-MPA). This dendritic architecture was selected for the 
excellent biocompatibility, stability under physiological conditions and biodegradability of the 
bis-MPA core 35, which makes it suitable for clinical applications. Arg was coupled to the 
dendron through stable amidic bonds. Wender demonstrated that the chirality of the amino acids 
of TAT has a negligible effect on the cellular uptake of this class of molecules.36 Therefore, the 
stereochemistry of the resulting Arg-decorated dendron was not an issue in this work. 
The divergent synthesis of the bis-MPA/bis-AMPA based dendron yielded multiple-arm 
derivatives classified as generation (G) that corresponds to the consecutive branching points each 
of them end-terminating with four amino groups for Arg coupling. Notably, TAT possesses 6 
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Arg (sequence: GRKKRRQRRRPQ). Therefore, the G1 and G2 bis-MPA based dendrons, which 
bear 4 and 8 Arg, respectively, have the closest number of Arg to the natural TAT.  
The charge density of CPPs has been shown to play a key role in the cell glycocalyx cross-
linking and cell penetration. Accordingly, we investigated the charge density of the G1 and G2 
Arg-decorated dendrons as predicted from the average mutual distance of Arg using the 
Molecular Operating Environment (MOE) software (Chart 1).14  
 
 
Chart 1. Structures of first generation (G1) dendron Arg4-DAG (A) and second generation (G2) 
dendron Arg8-DAG (B). 
 
The in silico simulation showed that the carbon atoms of adjacent guanidinium Arg residues are 
separated by 10.3 Å and 13.8 Å in G1 (4 Arg) and G2 (8 Arg) dendrons, respectively. This result 
suggests that G1 dendron has higher charge density than G2 dendron. It is worth to note that 




performance of short peptides in nanocapsular systems, showing that carriers functionalized with 
short peptides with only three Arg are efficiently taken-up by the cells. This was ascribed to the 
cooperative effect that oligo-Arg on the nanocarrier surface.37 
The dendron design included the end-functionalization with a diacyl glycerol unit, 3-(1,2,3-
triazol)propane-1,2-distearate (DAG), to yield its association with the liposomal membrane. 
Considering that the resulting [hydrophobic alkyl chains]/[polycationic dendritic block] mass 
ratio was  1:2.8 and 1:4.6 for the G1 derivative (4 Arg) and the G2 derivative (8 Arg), 
respectively, the former, that contains a heavier anchoring fraction with respect to the latter, was 
expected to more stably associate with the lipid bilayer of the liposome membrane. Therefore, 
taking into account the higher positive charge density and the lighter cationic block, the G1 
dendron bearing four Arg (Arg4-DAG) was selected.  
The synthetic procedure set-up for the production of Arg4-DAG provided for high structural 
control and monodispersity of the branched derivative, and high functional group density at the 
terminal ends (namely the Arg). Feliu et al.35 investigated the stability, degradability and 
cytotoxicity of bis-MPA based dendrons under different conditions and demonstrated the 
excellent biocompability and potential for exploiting these scaffolds for biomedical applications. 
 
3.2 pH-sensitive block-copolymer synthesis and characterization 
The acid-sensitive mPEG-(poly-methacryloyl-sulfadimethoxine) (mPEG-polySDM) stealthing 
block co-polymer (17) was designed to yield Arg4-DAG shielding and unshielding at the 
surface of CPE-decorated liposomes.  
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The ionizable sulfadimethoxine (SDM) block was selected to provide the coulombic interaction 
of the co-polymer with the polycationic CPE.  Actually, by virtue of its pKa (6.1),38 SDM 
reversibly switches from anionic to uncharged state over a narrow pH range close to 
physiopathological conditions. According to the evidence that the pKa of SDM oligomers 
increases with the number of monomers,22, 39 a block mPEG-polySDM co-polymer formed by 7 
SDM monomers was synthesised. The potentiometric titration profile reported in Figure S2 (ESI) 
shows that this copolymer has pKa 7.1. This result is in agreement with polymers obtained with 
PEG derivatives and SDM reported in the literature.22, 39-40 Therefore, this co-polymer  is 
predominantly in the polyanionic form at pH 7.4 of blood, which allows for the charge-to-charge 
association with the CPEs on the liposome surface, while it switches to a less charged form at 
pH 6.5 of the tumor22 which translates in a weaker electrostatic interaction with the 
cationic liposomes resulting in detachment from their surface and CPE unmasking 
(see chapter 3.4).   
The length of the PEG block was selected according to the literature reports showing 5 kDa 
mPEG minimizes the protein opsonisation of nanocarriers and their removal by the RES system, 
yielding prolonged permanence in the bloodstream.32, 41 
 
3.3 pH-sensitive liposome formulation  
Arg4-DAG decorated liposomes were prepared by rehydration of a thin lipid layer
23 and CPE 
decoration by a spontaneous micelle transfer post-insertion technique,42 which provided for the 
CPE exposure on the outmost layer of the lipidic vesicles and reduced the hiding of the Arg4-
DAG in the liposome core. 
 21 
Liposomes decorated with increasing Arg4-DAG/lipids molar ratio (from 1 to 8 mol%) were 
prepared  according to the protocols reported in the literature for liposomes decorated with TAT-
like derivatives.43-45 The Arg4-DAG association to the liposome bilayer was assessed by zeta 
potential analysis. In PBS, pH 7.4, the non-decorated control liposomes exhibited a zeta potential 
that was nearly neutral (i.e. -1 mV) while the results reported in Figure 1A show that the zeta 
potential of the liposomes increased as the Arg4-DAG concentration on the vesicle surfaces 
increased up to a plateau of +24 mV at 4 mol% Arg4-DAG/lipid ratio. These results suggest that 
there is a limit of Arg4-DAG association with the liposome membrane that could be explained 
with a charge repulsion effect, being the Bjerrum length at 150 mM ionic strength still similar 
to that in water, 7 Å. The limited Arg4-DAG association was confirmed by the Sakaguchi 
assay,46 which showed that more than 90% of the Arg4-DAG was associated to the lipid bilayer 
when Arg4-DAG/lipid molar ratios between 1 and 4 mol% were used to assembled liposomes 
while the efficiency of the CPE association to the lipid bilayer decreased from 90% to ~50% 


















Figure 1. (A) Size (●) and zeta potential (□) profiles of liposomes decorated with increasing 
Arg4-DAG/lipid ratio at pH 7.4 in PBS; (B) Zeta potential of liposomes coated with 4 mol% CPE 
at pH 7.4 (□) and 6.5 (■) in different buffers; statistical analysis: * p<0.05; ** p<0.01; *** 
p<0.001. (C) Small angle x-ray scattering spectra of CPE alone (■) and liposomes before (■) and 
after (■) incubation with Arg4-DAG. T = 25 °C, HEPES buffer pH 7.4.  
 
Zeta potential analyses were performed in HEPES/NaCl or HEPES/mannitol at pH 7.4 and in 





















































































osmotic activity on biophysical properties of Arg4-DAG decorated liposomes.
47 The zeta 
potential values determined at pH 7.4 (mimicking the blood) were slightly lower than that at pH 
6.5 (mimicking the tumour) regardless the buffers used for the analysis (Figure 1B). This result 
indicates that the overall positive charge on the liposome surface conveyed by the CPE increased 
as the pH decreased, despite the high pKa of the guanidinium group of Arg (pKa 12.48).48 The 
positive charges of the Arg4-DAG decorated liposomes in phosphate (anionic buffer) at both pHs 
(7.4 and 6.5) was slightly lower than in HEPES or MES (zwitterionic buffers) indicating that the 
anionic species of the buffer partially quenched the Arg of Arg4-DAG. No significant differences 
were instead observed with different osmotic agents (mannitol and NaCl). Thus, charge shielding 
of Arg4-DAG by buffer and osmotic agents in the aqueous medium may  be related to the size of 
the buffer species and their overall molecular charge distribution.  
Based on the zeta potential analysis, HEPES (at pH 7.4) and MES (at pH 6.5) were used as 
buffers for the extensive biophysical characterization of the pH-responsive liposomes under 
environmental pHs that mimic the healthy tissue and the tumor. These two buffers are 
extensively used to prepare and characterize colloidal drug carriers.49  
Figure 1A shows that the plain and the decorated liposomes had a vesicle size of 178±14.5 nm 
and 180±13.3 nm, respectively, with a narrow polydispersity index (PDI 0.06), which indicates 
that the decoration with the synthetic CPE did not alter the formulation size. Furthermore, no 
size alteration was observed after 48 hours incubation at 37 °C, which confirms a good colloidal 
stability of the vesicles as a result of the charge mediated repulsion that inhibited aggregation. 
SAXS studies were performed to assess the structure of decorated liposomes. The X-ray 
scattering spectra reported in Figure 1C show that Arg4-DAG (CPE) alone formed small micelles 
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(red squares in Figure 1C), which was confirmed by a fluorescence assay used to assess the 
critical micelle concentration (CMC= 40 μM). The 2:1 (mol/mol) 
phosphatidylcholine/cholesterol liposomes before and after incubation with Arg4-DAG (black 
and blue dots) showed the fingerprint of the multi-layer vesicles. Before Arg4-DAG incubation 
(black dots), two peaks with different intensity, at q1 = 0.86 nm
-1 and q2 = 1.72 nm
-1, were 
superimposed to the form factor of the individual lipid bilayer. The 1-2 periodicity of these peaks 
is typical of a stratified liposome, with a repetition distance d = 2/q1 = 7.3 nm, which is in 
agreement with values reported in the literature for similar 2:1 (mol/mol) 
phosphatidylcholine/cholesterol layers.50 The spectrum obtained with liposomes after incubation 
with CPE at pH 7.4 is similar to that obtained at pH 6.5 (Figure 2C, green diamonds). Upon 
incubation of the liposomes with the CPE, the intensity profile dramatically changed, indicating 
that interaction between admixed components occurred. The final spectrum could not be 
obtained by simple superposition of the two, as shown in Figure S3 of the ESI. The intensity 
enhancement of the single-bilayer form factor and its better definition was typical for charge-
bearing liposomes, as compared to uncharged. Multilamellarity was still observed, with the same 
repetition distance, showing that CPE insertion occurred only in the external bilayer of the 
liposome. Then, the liposome constituted a support for the CPE that decorated its surface without 
deeply affecting the liposome structure. 
 
3.4 pH-controlled shielding of CPE decorated liposomes 
The cancer cell interaction were investigated using 4 mol% Arg4-DAG decorated liposomes 
coated with the pH-sensitive block co-polymer mPEG5kDa-SDM8.  
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The zeta potential analysis showed that the increase of the [pH-sensitive polymer]/[Arg4-DAG] 
molar ratio decreased the vesicle charge due to the coulombic interaction of the polyanionic co-
polymer with the polycationic liposomes. The zeta potential values reported in Figure 2A show 
that at both pH, 7.4 and 6.5, the overall charge of the decorated liposomes decreased as the 
mPEG5kDa-SDM8/Arg4-DAG molar ratio increased. At pH 7.4, the 1:1 mPEG5kDa-SDM8/Arg4-
DAG molar ratio yielded complete liposome charge quenching, while at pH 6.5 a residual charge 
(+11 mV) was registered. This behaviour is ascribable to the pH dependent ionization of the 
polyanionic co-polymer. At pH 7.4 and 6.5, an average of 5.2 and 1.6 sulfadimethoxines (SDM), 
respectively, was calculated to be in the anionic form for each mPEG5kDa-SDM8 unit (pKa 7.1), 
which resulted in an unlike ability to quench the positive charges of the Arg of the CPE and thus 
associating with the CPE-decorated liposomes. Notably, since the pH-sensitive liposomes at pH 
6.5 are generated by pH shift from formulations at pH 7.4, the positive zeta potential of these 
liposomes at pH 6.5 supports a significant detachment of the mPEG5kDa-SDM8 during pH 
shifting as a consequence of the decrease of the co-polymer anionic charges (as discussed in 
chapter 3.2). On the contrary, the zeta potential is nearly neutral when pH-sensitive liposomes 
are generated at pH 7.4. The residual anionic charge of the polymer at pH 6.5 due to its apparent 
pKa may account for the incomplete recovery of the zeta potential of liposomes at this pH since a 
fraction of the polymer may be still associated to the vesicles surface. Indeed, the detachment of 
mPEG5kDa-SDM8 from liposome surface started at pH below 7 and was more remarkable as the 
pH of incubation decreased to 6.0 as a result of more extensive polymer detachment from 
liposomes (Figure S4). 
Zeta-potential analysis of Arg4-DAG decorated liposomes incubated with 1:1 mPEG5kDa-
OH/Arg4-DAG molar ratio showed that the ionically neutral 5 kDa mPEG5kDa-OH was not able 
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to associate with Arg4-DAG. Similarly to other anionic species present in the saline buffer, also 
the ionisable single SDM molecules incubated with the Arg4-DAG decorated liposomes at a 8:1 
SDM/Arg4-DAG molar ratio were not found to associate with the Arg4-DAG indicting that the 
cooperative effect of multiple anionic charges of the oligo-ionic mPEG5kDa-SDM8 was required 
to associate with the CPE. Notably, this electrostatic interaction finally resulted in the physical 
PEGylation of the liposomes at pH 7.4 and charge screening.  
Size analysis showed that at pH 7.4 the mPEG5kDa-SDM8 coating of Arg4-DAG decorated 
liposomes yields a slight vesicle size increase, which supports for the association of the pH-
responsive polymer to the CPE decorated liposomes in agreement with data reported in the 
literature for post-insertion PEGylation of liposomes with 5 kDa PEG.51 The size and zeta 
potential analyses showed that the polymer coated vesicles were colloidally stable over 2 days 
while CPE-decorated liposomes (no mPEG5kDa-SDM8) showed instability after 48 hours (Figure 
















Figure 2. (A) Zeta potential (bars) and size (■) of Arg4-DAG decorated liposomes in the 
presence of mPEG5kDa-SDM8 at increasing mPEG5kDa-SDM8/Arg4-DAG (pH sens. polym. / CPE) 
feed molar ratio, at pH 7.4 (□), 6.5 (■). (B) Small angle x-ray scattering spectra of Arg4-DAG 
decorated at pH 7.4, before (♦) and in the presence of mPEG5kDa-SDM8 (♦) and (C) at pH 6.5, 
before (♦) and in the presence of mPEG5kDa-SDM8 (♦).  
 
SAXS spectra of Arg4-DAG decorated liposomes at pH 7.4 (B) and pH 6.5 (C) reported in 
Figure 2 show that the mPEG5kDa-SDM8 addition modified the scattering profile of the liposomal 
dispersions. The internal structure was maintained for both systems, as shown by the persistence 
of the intensity peak at q1 = 0.86 nm-1, revealing that the multi-layered liposomal core structure 
was preserved, with the same repeat distance, 7.3 nm. Also, intensity oscillations in the higher q 
region of the spectra display similar features, indicating that the individual lamellae maintain the 









































































































































































(Figure 2B) than at pH 6.5 (Figure 2C) by the addition of mPEG5kDa-SDM8. Altogether, these 
results suggest that modifications were mainly related to the structure of the outer shell of the 
liposomes. At pH 7.4 a large association of the pH-sensitive polymer with the external surface of 
decorated liposomes can be inferred, while at lower pH the scattering profile was consistent with 
the presence of free PEG in solution. An example of reconstruction of the experimental data is 
reported in Figure S6 of the ESI. 
Surface plasmon resonance (SPR) studies were performed to further investigate the association 
of the pH-sensitive polymer with CPE decorated liposomes immobilized on sensorichip (Figure 
S7 in ESI).26, 52-53 The real-time SPR profiles to increasing additions of mPEG5kDa-SDM8 to Arg4-
DAG liposomes reported in Figure 3A show that at pH 7.4 the SPR response was considerably 
higher than at pH 6.5. This result confirms that mPEG5kDa-SDM8 interacted more efficiently at 
pH 7.4 than at pH 6.5 as a consequence of the fact that at pH 7.4 and pH 6.5 each mPEG5kDa-







Figure 3. (A) Representative MP-SPR signal responses during interaction of increasing 
concentrations of mPEG5kDa-SDM8 at pH 6.5 (▬) and 7.4 (▬) through in situ PEGylation of 
Arg4-DAG liposomes immobilized on the SPR sensor surface. Down arrows indicate injection 
time points of the pH-sensitive polymer, while stars indicate injection time points for the running 
 pH 6.5 pH 7.4 
Bmax (m) 118 435 
 1.64 2.17 
(Kco)
 (M-1) 7.75×109 5.74×1011 
Kco (M-1) 1.07×10
6 2.63×105 
R2 0.997 0.999 
A B 
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buffer. (B) Binding isotherms at pH 6.5 (■) and 7.4 (■) for mPEG5kDa-SDM8 interaction with 
Arg4-DAG decorated liposomes immobilized on the SPR sensor surface (N=3). Dashed black 
lines are fits of the co-operative binding model to the data points. Table: Bmax values, 
cooperativity coefficients (α), overall cooperative binding constant (Kco)α, and average 
cooperative binding constant (Kco) at pH 6.5 and 7.4 for mPEG5kDa-SDM8 interaction with Arg4-
DAG liposomes immobilized on the SPR sensor surface. 
 
 
Since the association of mPEG5kDa-SDM8 with Arg4-DAG liposomes involves multiple charge 
interactions, multivalent ligands and multi-subunit substrates, the binding constants and 






𝛼.    (1) 
where B = SPR signal response, [P] = concentration of mPEG5kDa-SDM8, α = co-operativity 
coefficient and Kco = average cooperative binding constant. If the co-operativity of the binding is 
positive, then the first ligand facilitates the binding of the next ligand. If the co-operativity of the 
binding is negative, then each subsequent ligand is bound less strongly than the previous one. 
One-site, positive and negative co-operative binding models are obtained when the co-operativity 
coefficient α is 1, α > 1 and α < 1, respectively. The binding constants K1, K2, …, KN for each 
charged interaction will not be the same and, therefore, only average co-operative binding 
constants can be obtained, i.e. Kco that is the average co-operative binding constant and Ktot = 
(Kco)
α that is the overall average co-operative binding constant. 
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Figure 3B shows the co-operative binding isotherm of mPEG5kDa-SDM8 interaction with Arg4-
DAG decorated liposomes immobilized on the SPR sensor surface. The regression coefficients 
fitting co-operative models at pH 6.5 and 7.4 were 0.997 and 0.999, respectively. The Bmax value 
obtained at pH 7.4 was almost 4 times higher than at pH 6.5, which was consistent with much 
higher association of mPEG5kDa-SDM8 with the Arg4-DAG decorated liposomes at pH 7.4 as 
discussed above. The co-operativity coefficients at both pH values are clearly larger than 1, 
which suggests that the interaction of mPEG5kDa-SDM8 with Arg4-DAG liposomes displays a 
positive co-operativity at both pH values. The overall average binding constants Ktot = (Kco)
α had 
very high values and was higher at pH 7.4 (i.e. 5.74×1011) than at pH 6.5 (i.e. 7.75×109), which 
once again corroborates the higher association of mPEG5kDa-SDM8 with Arg4-DAG liposomes at 
pH 7.4. However, the average binding constants (Kco) showed a reverse trend indicating a higher 
value at pH 6.5 (i.e. 1.07×106) compared with pH 7.4 (i.e. 2.63×105). This kind of behavior is 
expected for systems exhibiting strong positive co-operativity as the individual binding constant 
increases with each bound ligand, i.e. K1 < K2 < K3… until the saturation limit is reached, 
which results in that Ktot >> Kco. Furthermore, the smaller the Kco value the higher the charge 
ratio is required to reach the saturation level of the system, which was also reflected in the 
interaction of mPEG5kDa-SDM8 with Arg4-DAG liposomes when comparing the two different pH 
conditions. 
Since liposomes are exposed to serum proteins upon parenteral administration, stability studies 
were performed by incubation in foetal bovine serum (FBS) at pH 7.4 and 6.5 (Figure 4). The 
size increase of CPE-decorated liposomes at both pHs could be ascribed to a combined effect of 
“protein corona” formation due to the high positive zeta potential and possible aggregation. This 
hypothesis is in agreement with results reported in the literature56-57 including the SPR 
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measurements of protein adsorption on the oligo-arginyl decorated liposomes we reported in our 
previous studies.53 mPEG5kDa-SDM8 coating reduced the liposome size increase at pH 7.4 
indicating that the pH-sensitive polymer reduced the opsonization of the cationic liposomes. This 
result is also in agreement with our SPR outcomes reported in the literature showing that the 
CPE decorated liposomes coated with polyanionic-PEG display a thinner protein corona with 
respect to the polyanionic-PEG free formulation.53 On the other hand, at pH 6.5 in the presence 
of FBS, the dissociation of the mPEG5kDa-SDM8 from the liposome induced a size increase of the 
vesicles that was comparable to that of the mPEG5kDa-SDM8 free CPE-decorated liposomes 
confirming that, under this pH condition, the liposome surface was prevalently exposed to 












Figure 4. Size of CPE decorated liposomes (A) and CPE decorated liposomes formulated with 
mPEG5kDa-SDM8 (B) in 0.0 1 M HEPES, 0.15 M NaCl at pH 7.4  and 0.01 M MES, 0.15 M 






































3.5 Biological Studies 
3.5.1 Effect of CPE on liposome association to cells 
Cell association and internalization studies were carried out using naked liposomes (control) and 
2 and 4 mol% Arg4-DAG decorated liposomes labelled with rhodamine-DHPE.  
The cytofluorimetric results reported in Figure 5A show that the cell association increased with 
the Arg4-DAG density on liposome surface. The decoration of liposomes with 4 mol% CPE (zeta 
potential = +28 mV) increased the liposome association to cells of 31 times (referred to the MFI) 
with respect to naked liposomes (zeta potential = -1 mV) and 11 times with respect to 2 mol% 
Arg4-DAG decorated liposomes (zeta potential = +13 mV).  
Cell association of the CPE-decorated liposomes can be mediated by the protein corona adsorbed 
on liposome surface.56 However, despite the presence of the protein corona, interaction of the 
CPEs with the cell glycocalyx when liposomes approach the cell membrane may take place and 
mediate the association of the liposomes with HeLa cells. Further investigations are required to 
elucidate in details at molecular level the mechanism of cell entry mediated by this novel CPE 














Figure 5. (A) Cytofluorimetric profile of HeLa cells incubated with naked liposomes (naked 
lipos.), liposomes decorated with 2 mol % (2% CPE/lipos.) and with 4 mol% (4% CPE/lipos.) of 
Arg4-DAG in medium at pH 7.4. (B) Confocal microscopic images of HeLa cells incubated with 
fluorescently labelled naked liposomes and (C) liposomes decorated with 4 mol% of Arg4-DAG 
in medium at pH 7.4. (D) Magnification of the white square in (C) and Z-stack projection. Cell 
nuclei were stained with DAPI (blue), membranes with WGA-AlexaFluor 633(green) and 
liposomes were fluorescently labelled with Rhodamine-DHPE (red).  
 
The confocal microscopic analysis confirmed that the CPE decoration remarkably enhanced the 
liposome association to cells and showed the vesicles accessed to the HeLa cell cytoplasm 
(Figure 5 B-D). The cytoplasm disposition of liposomes was confirmed by the z-stack projection 
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mainly located within the cytosol and disposed in proximity of the cell membrane (green) a and 
not in the nucleus (blue).  
 
3.5.2 pH-controlled association of CPE-decorated liposomes to cancer cells  
CPE-decorated liposomes (4 mol% Arg4-DAG/lipids) coated with the pH-sensitive co-polymer 
mPEG5kDa-SDM8 (1:1 Arg4-DAG/mPEG5kDa-SDM8 molar ratio) were tested with HeLa cancer 
cells at pH 7.4 and 6.5, which mimic blood and extracellular tumour environments, respectively. 
HeLa cells were selected since they are a well-established cancer cell model. Anderson and co-
workers extensively characterized the tumor generated with these cells. He showed that 
interstitial space of this tumor has pH 6.5 ± 0.2.60 Thus, we identified pH 6.5 a representative 
condition to investigate association of the pH responsive liposomes with this model cell line. 
Figure 6A and B shows that at pH 6.5 the cells displayed a 6-fold higher mean fluorescence 
intensity (MFI) with respect to pH 7.4. Almost all cells (99%) were fluorescently positive to 
liposomes at pH 6.5 while cells were mostly spare from interaction with pH responsive 
liposomes when incubated at pH 7.4. Studies showed that mPEG5kDa-SDM8-free CPE-decorated 
liposomes massively associated with the cells regardless the incubation pH (Figure 5A, and 
Figure S8and S9 in ESI). Furthermore, control liposomes decorated with 4 mol% of commercial 















Figure 6. (A) Cytofluorimetric profile of HeLa cells incubated with rhodamine-DHPE labelled 
mPEG5kDa-DSPE coated liposomes, and CPE-decorated liposomes with pH-responsive polymer 
in medium at pH 6.5 and 7.4. (B): relative MFI% of cells incubated with liposomes in medium at 
pH 7.4 (■) and 6.5 (■) derived from Figure (A). 100% relative MFI was attributed to cells 
incubated with CPE-decorated liposomes in medium at pH 7.4.  Statistical analyses: * p<0.05; ** 
p<0.01; *** p<0.001. (C) Confocal microscopic images of HeLa cells incubated with: 
mPEG5kDa-DSPE coated liposomes, and CPE-decorated liposomes with pH-responsive polymer 
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decorated liposomes with and without pH-responsive polymer in medium at pH 7.4 and 6.5 at 
0.1 (■), 0.5 (■) and 1 (■) mg/mL for 6 hours. 
 
The confocal microscopy images reported Figure 6C confirmed the pH controlled association of 
the mPEG5kDa-SDM8 coated Arg4-DAG decorated liposomes with HeLa cells. The intense cell 
associated fluorescence detected at pH 6.5 was a consequence of the dissociation of mPEG5kDa-
SDM8 from the Arg4-DAG units on liposome surface which restored the CPE on the liposome 
surface yielding their preferential association to cells under acid conditions. On the contrary, at 
pH 7.4 only few red fluorescent spots were detected on the outer cell surface in proximity of cell 
membrane.  
Oppositely to several cationic liposomes that display inherent high cytotoxicity61  Figure 6D 
shows that the Arg4-DAG decorated liposomes possessed a negligible cell toxicity, which was 
similar to that of naked liposomes. Recent studies proved that cationic liposomes obtained by 
Arg decoration cause low cell toxicity when compared to the positive control Lipofectamine™ 
2000. This result was attributed to the presence of amino acid analogs within the lipidic 
composition,62 which may provide a different interference of the liposomes with the membrane 
function and integrity of the cell or the subcellular compartments with respect to commercial 
lipids such as DOTAP.63-64 Notably, the presence of the pH-responsive polymer, both at pH 7.4 
and 6.5, did not alter the biocompatibility of the CPE-decorated liposomes. 
Interestingly, a control study carried out with human epithelial PNT2 cells, at pH 7.4, showed 
that under physiological conditions the pH responsive liposomes do not significantly interact 
with non-cancer cells (Figure S10). On the contrary, the CPE decorated liposomes showed an 
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unspecific remarkable interaction with the cells. This result further supports the environmental 
activation of the pH sensitive carrier, which can avoid interactions with normal cells under 
physiological conditions, namely at pH 7.4. 
 
3.5.3 Enhancement and pH controlled delivery of liposome payload 
Calcein and BSA loaded CPE-decorated liposomes were used to investigate the intracellular drug 
delivery.   
Calcein was chosen as model hydrophilic molecule that does not cross lipid bilayers, thus it 
mimics drugs with negligible access to the intracellular compartment.65 The calcein loaded CPE-
decorated vesicles displayed a size of 187 ± 8 nm with a polydispersity index of 0.117, and the 
loading capacity and encapsulation efficiency were found to be 52 µg calcein/mg lipids and 
5.6%, respectively. 
Proteins possess low permeability across biological membranes while the intracellular delivery 
can have therapeutic applications for those possessing cytosolic targets. Thus, a delivery system 
is required to promote the access of these macromolecules to the intracellular targets.66 BSA was 
selected as model biomacromolecule since it was already exploited to study the delivery of 
proteins encapsulated in liposomes.67 Proteins with surface hydrophobic regions, such as BSA,68 
may favorably associate with the lipidic components of liposomes during the loading process and 
thus be suitably encapsulated. Notably, a consensus exists concerning the favorable effect of the 
protein/lipid interaction on the protein loading efficiency in liposomes.69 Although extensive 
BSA labelling was considered useful to emphasize the cell up-take results, in the present study, 
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BSA was labelled with a minimal amount of Rhodamine (3 Rhodamine molecules per BSA, 
Figure S11) in order to avoid structural protein alteration. BSA-Rho loaded CPE-decorated 
liposomes were obtained with a size of 201 ± 6 nm and a polydispersity index of 0.197. The 
slight size increase of BSA-Rho loaded liposomes with respect to their non-loaded counterparts 
was already observed in our previous work.67 After removal of the non-loaded BSA-Rho, RP-
HPLC analysis indicated a loading capacity of 25.2 µg BSA-Rho/mg lipids and an encapsulation 
efficiency of 2.52 %. 
The release study from CPE-decorated liposomes was carried out in buffer at pH 7.4 and pH 6.5, 
mimicking the blood and extracellular tumour environments, respectively (Figure 7).  
Preliminary studies confirmed that calcein fluorescence is not affected by the pH. The study 
showed that the encapsulated calcein is not released by liposomes at the two pH conditions for at 
least 16 days, which is consistent with the low permeability of calcein across the lipid bilayer65 





Figure 7. Calcein (A) and BSA-Rho (B) release profile from CPE-decorated liposomes in PBS 

















































The release profiles reported in Figure 7B indicate that the release of BSA-Rho is quite slow in 
the first 6 hours and that approximately 30% of the loaded protein was released in 24 h. Notably, 
BSA-Rho release was complete in about 7 days. The release profile was very similar to that 
observed for PEG decorated liposomes reported in our previous study.67 To note that the 
decoration of liposomes with CPE, as well as the pH conditions (Figure S12), neither altered the 
loading capacity nor the release profile of the vesicles. 
The enhancement of delivery of small hydrophilic molecules to cancer cells was tested with 
calcein loaded CPE-decorated liposomes. The results of the flow cytometric investigation 
reported in Figure 8A, showed the ability of the CPE-decorated vesicles to deliver calcein to 
HeLa cells while the free calcein and calcein loaded naked liposomes did not associate to the 
cells. All cells treated with CPE-decorated liposomes showed a higher fluorescence intensity 







Figure 8. Cytofluorimetric profile (A) and confocal microscopic images (C) of HeLa cells 
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liposomes decorated with 4 mol% of Arg4-DAG (calcein in CPE/lipos.) in medium at pH 7.4.  
The last right image of panel (C) represents a magnification of the image of cells incubated with  
“calcein in CPE/lipos” and the corresponding z-stack.  Cell nucleus was stained with DAPI in 
blue, cell membrane is represented in green upon staining with WGA-AlexaFluor 633, and 
calcein in red. Panel (B) schematically represents the calcein loaded liposomes.  
 
Confocal microscopy confirmed the disposition of calcein within the cytosol when delivered by 
CPE-labelled liposomes (Figure 8C) while a very low cell associated fluorescence of calcein was 
detected neither when cells were incubated with equimolar concentration of free calcein, which 
was expected due to the limited cell membrane permeability of this molecule, nor when 
incubated with calcein loaded naked liposomes.  
The cytofluorimetric data reported in Figure 9A and B show that 1 h incubation with BSA-Rho 
loaded CPE-decorated liposomes yielded 33% fluorescently positive cells and higher mean 
fluorescence intensity (MFI) compared to free BSA-Rho and BSA-Rho loaded naked liposomes 














Figure 9. Cell association of BSA-Rho loaded liposomes with HeLa cells. (A) Cytofluorimetric 
profiles, (B) relative MFI%, and (C) confocal microscopic images of HeLa cells treated with free 
BSA-Rho, naked liposomes and CPE-decorated liposomes loaded with BSA-Rho in medium at 
pH 7.4. Panel (D) schematically represents CPE-decorated liposomes loaded with BSA-Rho. 
Statistical analyses: * p<0.05; ** p<0.01; *** p<0.001. 
 
The confocal microscopy images reported in Figure 9C show that after cell incubation with 
BSA-Rho loaded CPE-decorated liposomes, BSA-Rho disposed intracellularly while no 
intracellular fluorescence was observed by cell incubation with free BSA-Rho and BSA-Rho 
loaded naked liposomes. These results prove that Arg4-DAG decorated liposomes can efficiently 
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The different cell up-take of BSA-Rhodamine and calcein loaded Arg4-DAG decorated 
liposomes  observed by cytofluorimetry and confocal microscopy (Figure 8 and 9) is ascribable 
to the different fluorescence quantum yield  and content of the two fluorophores (rhodamine and 
calcein) in the formulations. 
The pH controlled delivery of calcein to cancer cells was tested by incubating HeLa cells with 
calcein loaded CPE-decorated liposomes formulated with mPEG5kDa-SDM8 at pH 7.4 and 6.5. 
The cytofluorimetric analysis indicated that the pH-sensitive liposomes selectively delivered 
calcein to the cells under tumour acid environment. In fact, cells incubated with the pH 
responsive formulation at pH 7.4 (mimicking the blood) displayed a 6.8 times lower MFI with 
respect to cells incubated with the same formulation at pH 6.5 mimicking the tumour (Figure 








Figure 10. (A) Cytofluorimetric profiles of HeLa cells incubated with calcein-loaded CPE-
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calcein was used as reference). (B) Relative MFI% of HeLa cells at pH 7.4 (■) and 6.5 (■) from 
panel (A); statistical analyses: * p<0.05; ** p<0.01; *** p<0.001. (C) Confocal microscopic 
images of HeLa cells treated with calcein loaded CPE-decorated liposomes with mPEG5kDa-
SDM8 at pH 7.4 and 6.5 and schematic representation of the CPE unshielding process triggered 
at acid pH (D).  
 
The confocal imaging study (Figure 10C) also confirmed that, while calcein encapsulated in the 
CPE-decorated liposomes remarkably disposed in the cell cytosol regardless of the incubation 
pH (Figure 8 and S13 in ESI), the calcein intracellular delivery by the pH responsive liposomes 
was higher under acidic pH (6.5) with respect to pH 7.4 (Figure 10C).  
These results confirmed that these pH-sensitive liposomes are efficient vehicles for controlled 
and preferential intracellular delivery of loaded molecules that, otherwise, would not access the 
cytosol across cell membranes and can be exploited for site-selective association to and uptake 
by cancer cells under the tumour matrix pH. Furthermore, the pH-guided intracellular delivery of 
drugs using these pH-sensitive liposomes may provide a valuable strategy to enhance the access 
to cancer cells after accumulation in the tumor while minimizing off-site toxicity to healthy 
tissues. Further studies are in progress to elucidate the intracellular trafficking of these liposomes 
and the payload release mechanism. Notably, evidences are reported in the literature that 





We have investigated here a novel strategy for site-programmed delivery of therapeutic 
molecules to cancer cells by combining on liposome surface a synthetic cell penetration enhancer 
and a polymeric pH sensor. These components modulate the surface features of the liposome 
according to a dynamic behaviour. The pH responsive PEG shielding prevents the carrier from 
the interaction with cells under condition mimicking the physiological environment, namely 
blood and extracellular environment of healthy tissues, while revealing the cell penetration 
enhancer on the liposome surface which guides the access of the lipidic vesicles to the cytosol of 
cancer cells under environmental conditions that are significant for certain diseases such as those 
of the tumour matrix.  
The responsiveness and efficacy of the system stems from the physicochemical features of the 
two poly-ionic components combined on the vesicle surface and from the strategy and ratio of 
assembly of these functional components. Therefore, the sequential decoration of liposomes with 
the CPE and the coating with the PEGylating masking agent has allowed the generation of 
“smart” vesicles for site-selective drug delivery.  
The results reported in this work demonstrate that the environmentally controlled shielding-and-
revealing strategy can provide for enhanced cancer cell delivery of drug loaded liposomes 
without using active biorecognition targeting. This strategy can be applied to a variety of 
nanocarriers to enhance site-selectivity to the tumour. Further studies will be undertaken to 
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